...
首页> 外文期刊>European journal of medical research. >In vivo-induction of Antibodies to Mistletoe Lectin-1 and Viscotoxin by Exposure to Aqueous Mistletoe Extracts: A Randomised Double-blinded Placebo Controlled Phase I Study in Healthy Individuals.
【24h】

In vivo-induction of Antibodies to Mistletoe Lectin-1 and Viscotoxin by Exposure to Aqueous Mistletoe Extracts: A Randomised Double-blinded Placebo Controlled Phase I Study in Healthy Individuals.

机译:暴露于槲寄生水溶液提取物中的槲寄生凝集素-1和粘菌毒素抗体的体内诱导:在健康个体中进行的随机双盲安慰剂对照I期研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Several studies have been performed in tumour patients to analyse the immunological response to mistletoe extracts. Considering the fact that these extracts are given subcutaneously in most instances, the kind of application resembles a typical immunization schedule. We therefore wanted to see how those extracts act on immunocompetent cells of healthy individuals hoping that this kind of provocation test may give new informations about a more specific application of these extracts in certain diseases. - Subjects/Methods: 47 healthy individuals were exposed for twelve weeks either to Iscador Quercus special (IQ) known to be rich in mistletoe lectin (ML)-1 (n = 16), to Iscador Pini (IP) being poor in ML-1 but enriched in viscotoxins (n = 15), or to placebo (physiological saline) (n = 16) in a randomised, double-blinded placebo-controlled study. Humoral immunoreactivity was analysed by measuring antibodies towards the two compounds ML-1 and viscotoxin VA2 (VA2). Sera were collected in intervals of four weeks up to week 12 and again three months after last exposure. - Results: None of the subjects had antibodies to ML-1 or VA2 before exposure. In week 12, anti-ML-1 antibodies of the IgG-type were found in all 16 IQ-treated individuals but only 6 of the 15 probands exposed to IP. In contrast, anti-VA2 IgG-antibodies could be detected in all individuals of both groups. The antibodies were preferentially of the IgG1 and IgG3 type while antibodies of the IgA and IgM type were produced only in a few probands. Antibodies of the IgE-type occurred only in the IQ-exposed individuals and were directed against ML-1 but not VA2. None of the probands receiving placebo developed antibodies to ML-1 or VA2. Severe side effects were not observed in any of the probands. - Conclusions: These data obtained in healthy individuals clearly indicate that IQ and IP-extracts can induce antigen-specific humoral responses. They may, therefore, provide, a solid basic for the evaluation of the humoral immune response in disease states.
机译:背景:已经对肿瘤患者进行了多项研究,以分析对槲寄生提取物的免疫反应。考虑到这些提取物在大多数情况下是通过皮下给予的,这种应用方式类似于典型的免疫方案。因此,我们希望了解这些提取物如何对健康个体的免疫能力细胞起作用,希望这种激发试验可以提供有关这些提取物在某些疾病中更具体应用的新信息。 -受试者/方法:将47名健康个体暴露于已知富含槲寄生植物凝集素(ML)-1(n = 16)的Iscador Quercus special(IQ),或暴露于ML--较差的Iscador Pini(IP),持续12周。 1例,但在一项随机,双盲安慰剂对照研究中,富含viscotoxins(n = 15)或安慰剂(生理盐水)(n = 16)。通过测量针对两种化合物ML-1和粘毒素VA2(VA2)的抗体来分析体液免疫反应性。直到第12周为止,每隔四个星期收集一次血清,最后一次暴露后三个月再次收集一次。 -结果:在暴露之前,没有受试者具有针对ML-1或VA2的抗体。在第12周中,在所有接受IQ的16位个体中均发现了IgG型抗ML-1抗体,但在暴露于IP的15位先证者中只有6位。相反,在两组的所有个体中都可以检测到抗VA2 IgG抗体。抗体优先为IgG1和IgG3类型,而IgA和IgM类型的抗体仅在少数先证者中产生。 IgE型抗体仅在暴露于IQ的个体中发生,并且针对ML-1,但不针对VA2。接受安慰剂的先证者均未开发出针对ML-1或VA2的抗体。在任何先证者中均未观察到严重的副作用。结论:在健康个体中获得的这些数据清楚地表明,IQ和IP提取物可以诱导抗原特异性的体液反应。因此,它们可以为评估疾病状态下的体液免疫反应提供坚实的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号